Baclofen EP Impurity B

Basic Information

View in Editor

CAS Number

1141-23-7

Molecular Formula

C11H12ClNO3

Molecular Weight

241.67 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Amines

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Agricultural Chemicals Pesticides Herbicides

Basic Physical Properties

Melting Point

168-170°C

SMILES

View in Editor

C1=CC(=CC=C1C(CC(=O)N)CC(=O)O)Cl

InChI

InChI=1S/C11H12ClNO3/c12-9-3-1-7(2-4-9)8(5-10(13)14)6-11(15)16/h1-4,8H,5-6H2,(H2,13,14)(H,15,16)

InChIKey

NLCJVRPOYTZTMS-UHFFFAOYSA-N

LogP

1.7736999999999996

Topological Polar Surface Area

80.39 Å²

Hydrogen Bond Donor/Acceptor

3 / 4

Complexity

262

Synonyms & References

English

3-(4-Chlorophenyl)glutaramic acid
1141-23-7
MFCD00190251
SCHEMBL7822991
AKOS003237766
Oprea1_563222
b -(4-Chlorophenyl) glutaric acid monoamide
(3RS)-5-Amino-3-(4-chlorophenyl)-5-oxopentanoic Acid
AC-19668
3-(4-Chloro phenyl) Glutaric acid monoamide
3-(p-Chlorophenyl)glutaramic acid
NS00006859
(3RS)-5-Amino-3-(4-chlorophenyl)-5-oxopentanoic Acid; Baclofen Imp. B (EP); Baclofen Impurity B
A803137
EC 700-336-4
5-amino-3-(4-chlorophenyl)-5-oxo-pentanoic acid
5-amino-3-(4-chlorophenyl)-5-oxopentanoic acid
DTXSID60405557
DS-10717
FT-0613655
5-amino-3-(4-chlorophenyl)-5-oxopentanoicacid
beta-(2-Amino-2-oxoethyl)-4-chlorobenzenepropanoic acid
Benzenepropanoic acid, beta-(2-amino-2-oxoethyl)-4-chloro-
(3r,s)-5-amino-3-(4-chlorophenyl)-5-oxopentanoic acid
CS-0151385
AMY3789
SY001982
JG2V9C2V9N
5-Amino-3-(4-chlorophenyl)-5-oxopentanoic acid
3-(4-Chlorophenyl)Glutaramic Acid
-(4-CHLOROPHENYL)GLUTARIMIDE

MDL Number

MFCD00190251

Customs Code

2924299090

FAQ

What regulatory guidelines apply to Baclofen EP Impurity B (CAS: 1141-23-7)?

Baclofen EP Impurity B (CAS: 1141-23-7) is subject to regulatory guidelines such as GHS classification, which categorizes it based on its physical, health, and environmental hazards. It also falls under REACH regulations, which require suppliers to register substances above a certain tonnage threshold. FDA and EPA have specific requirements for the handling, storage, and disposal of this compound. Compliance with these guidelines ensures safe and legal handling of the substance.

Are there alternatives to Baclofen EP Impurity B (CAS: 1141-23-7) in synthesis?

In synthesis, alternatives to Baclofen EP Impurity B (CAS: 1141-23-7) may include similar dihydropyridines or other muscle relaxants. Common alternative reagents like 4-chlorophenylacetic acid or other precursor chemicals can be used. However, these alternatives should be evaluated for their effectiveness and compatibility with the specific synthesis process.

What is the market or research trend for Baclofen EP Impurity B (CAS: 1141-23-7)?

The market for Baclofen EP Impurity B (CAS: 1141-23-7) is driven by its role as a byproduct in the synthesis of Baclofen, a muscle relaxant used to treat spasticity. Research trends focus on its pharmacological properties and potential applications. Market trends show a steady demand, but there is ongoing research to explore its use in new drug formulations and therapies.

How should waste containing Baclofen EP Impurity B (CAS: 1141-23-7) be handled?

Waste containing Baclofen EP Impurity B (CAS: 1141-23-7) should be collected in appropriate containers and stored in a secure, designated area. Incineration or professional waste disposal methods should be used to ensure safe destruction. Environmental protection precautions include following local and federal regulations for hazardous waste disposal. Proper documentation and labeling of waste are crucial for compliance and safety.